DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
Funds a phase 1 or small phase 2 ALS clinical trial that must start within a year of the award, with a biomarker built in for any drug, biologic or device.
About
Most promising ALS treatments never get tested in people quickly enough to matter. This award pays for the trial itself, and it wants it started fast.
A trial funded here has to fit one of two focus areas. Biomarker-Driven Interventions: a disease-modifying treatment paired with a biomarker that predicts who's likely to respond and shows the treatment is engaging its target. Clinical Care: a tria…
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.